Zhou Y, Song L, Xu Q, Zeng L, et al. Investigation on the survival implications of PD-L1 expression status in ALK- rearranged advanced non-small cell lung cancer treated with first-line crizotinib. Lung Cancer 2022;167:58-64.
PMID: 35405360